Towards Healthcare

Is Teva Pharmaceuticals Paving the Way for Affordable Diabetes Care with the Launch of the First-Ever Generic GLP-1 Product in the US? Teva Pharmaceuticals, a global leader in generics and specialty medicines, has announced the launch of its generic version of Victoza (Liraglutide injection 1.8 mg) in the United States. This groundbreaking product is the first-ever generic GLP-1 (glucagon-like peptide-1) receptor agonist to hit the US marketplace, marking a significant milestone in the treatment of type 2 diabetes mellitus. Liraglutide, originally marketed under the brand name Victoza by Novo Nordisk, is a medication that improves glycemic control in adults with type 2 diabetes and also reduces the risk of cardiovascular events such as heart attacks and strokes in patients with established cardiovascular disease. It works by mimicking the effects of the natural GLP-1 hormone, which helps regulate blood sugar levels, promotes insulin secretion, and reduces appetite. The launch of Teva’s generic version offers an affordable alternative for patients, providing broader access to this critical therapy. With the increasing prevalence of type 2 diabetes in the US and the significant burden of cardiovascular disease among these patients, Teva’s new generic option is expected to enhance treatment outcomes while reducing healthcare costs. This launch comes at a time when the demand for cost-effective diabetes treatments is growing, and Teva is poised to lead in delivering high-quality, accessible generic medications that meet the needs of patients and healthcare providers alike. Teva's generic version of Victoza is now available to healthcare professionals and patients across the United States, providing an important therapeutic option for managing type 2 diabetes and preventing cardiovascular complications. Generic Pharmaceuticals Market Inisght: https://lnkd.in/dC5q6jc8 Generic Sterile Injectable Market Insight: https://lnkd.in/ddVadrji Generic Drugs Market Insight: https://lnkd.in/dJAw8H5y We’ve prepared a service to support you. please feel free to contact us at [email protected] #TevaPharmaceuticals #GenericVictoza #Liraglutide #Type2Diabetes #GLP1 #DiabetesCare #AffordableHealthcare #CardiovascularHealth #HealthcareInnovation #DiabetesManagement #GenericDrugs #USPharma #PatientAccess

The long read sequencing (LRS) market was valued at approximately US$ 0.6 billion in 2023 and is projected to reach US$ 11.6 billion by 2034, growing at a remarkable compound annual growth rate (CAGR) of 30.96% from 2024 to 2034. The surge in genetic disorders, growing research and development efforts, and the rising demand for personalized medicine are some of the key factors fueling this growth. Get the latest insights on industry segmentation with our Annual Membership: https://lnkd.in/ds9rtPbb 10x Genomics: Known for single-cell sequencing, 10x Genomics provides tools to explore complex genetic data, transforming research on biological samples. Agilent Technologies: Offering precise and reliable genomic tools, Agilent supports global research and diagnostics, known for their accuracy in analysis. Azenta Life Sciences: Leading in sample management, Azenta recently launched an FDA-approved long-read whole genome sequencing service in the U.S. BGI Genomics: Provides cost-effective, high-throughput sequencing for applications from healthcare to environmental studies. Element Biosciences: Focuses on affordable, flexible genomic tools, enabling more labs to access advanced sequencing technology. Illumina: An industry staple, Illumina’s sequencing platforms support clinical and research applications, fueling advances in genetic insights. MGI: Known for high-precision sequencing tools, MGI aids institutions focused on healthcare and genomics. Oxford Nanopore Technologies: Pioneers in portable, real-time nanopore sequencing, allowing native DNA/RNA analysis in diverse settings. Pacific Biosciences (PacBio): Their SPRQ chemistry for the Revio system reduces input needs, increases data output, and expands multi-omics support. QIAGEN: Simplifies genomics workflows with user-friendly, versatile sequencing products for a range of studies. Quantapore, Inc.: Innovates high-resolution, cost-effective sequencing for both academic and clinical genomics. Thermo Fisher Scientific: Delivers high-quality sequencing platforms and reagents for healthcare and genomics research. Universal Sequencing Technology:?Specializes in accurate long-read sequencing for complex genetic disorder research and personalized medicine advancements. Buy Premium Global Insight: https://lnkd.in/dn_Pk8Be #Genomics #LongReadSequencing #Innovation #Healthcare #DNASequencing #Research #Biotechnology #PersonalizedMedicine #LRS

The global disposable safety lancets market was valued at approximately US$ 625 million in 2023 and is expected to grow to US$ 1,142.86 million by 2034, with a compound annual growth rate (CAGR) of 5.64% from 2024 to 2034. This growth is being driven by the increasing need for quick, convenient, and safe methods to monitor and assess various health parameters, which is fueling the demand for disposable safety lancets. As healthcare becomes more focused on ease of use and safety, the adoption of these devices continues to rise. Get the latest insights on industry segmentation with our Annual Membership: https://lnkd.in/ds9rtPbb Drawbridge Health: Launched NanoDrop, an FDA-approved at-home blood sampling device, for decentralized clinical trials. Roche – Accu-Chek: Introduced Accu-Chek SmartGuide, a real-time diabetes management system powered by AI. Becton Dickenson Dickinson: Known for precision with its Lancet Plus, a trusted choice for blood sampling. Ascensia Diabetes Care: Offers easy-to-use blood glucose meters, empowering diabetes management. LifeScan: Trusted for its OneTouch range of blood glucose monitoring devices. Nipro Medical EMEA Diagnostics: Offers Sure-Lancet, a safe and reliable blood sampling device. Abbott & Dexcom: Innovators in continuous glucose monitoring for real-time diabetes management. Buy Premium Global Insight: https://lnkd.in/dstJAPwq #HealthcareInnovation #DiabetesCare #MedicalDevices #SafetyLancets #AI #BloodSampling

The flow cytometry market, valued at $4.35 billion in 2023, is projected to grow to $9.16 billion by 2034, with a 7% CAGR driven by cancer prevalence, technological advancements, and increased research and development. Get the latest insights on industry segmentation with our Annual Membership: https://lnkd.in/ds9rtPbb Agilent Technologies Agilent provides essential tools for scientific research and diagnostics, empowering breakthroughs in genomics and chemical analysis. Beckman Coulter Life Sciences Known for their laboratory instruments, Beckman Coulter supports research in flow cytometry, cell analysis, and diagnostics. BD BD focuses on improving healthcare through innovative medical devices, diagnostic systems, and laboratory reagents. bioAffinity Technologies In October 2024, BioAffinity introduced the CyPath Lung, a non-invasive lung cancer detection test, using sputum to offer earlier diagnosis. Bio-Rad Laboratories In May 2024, Bio-Rad launched new StarBright Dyes, enhancing flow cytometry for immunological and translational research. Cytek Biosciences Cytek leads in advanced flow cytometry technology, aiding researchers in cancer, immunology, and cell biology studies. Danaher Corporation Danaher brings scientific and technological solutions to diagnostics and life sciences, improving healthcare globally. Labcorp Drug Developement. LabCorp supports drug development through integrated clinical trial services, speeding up the process of new drug discovery. Luminex Luminex offers high-throughput diagnostics, helping researchers in molecular diagnostics and clinical research. Sony Sony is advancing life sciences with imaging technologies that improve the analysis of biological samples. Sysmex America, Inc. Sysmex provides automated diagnostic tools, improving accuracy and efficiency in clinical labs worldwide. Thermo Fisher Scientific Thermo Fisher leads in research tools and laboratory equipment, supporting everything from drug discovery to environmental testing. Buy Premium Global Insight: https://lnkd.in/dGDeDm-s ?#LifeSciences #Innovation #MedicalTech #Biotech #Healthcare

Happy Radiology Day! Celebrated annually on November 8, this day marks Wilhelm Conrad Roentgen's 1895 discovery of X-rays, revolutionizing medicine and setting the stage for modern radiology. Radiology professionals are vital to healthcare, using imaging techniques like X-rays, MRI, and CT scans to diagnose and guide treatment for conditions such as cancer and cardiovascular diseases. As technology advances, radiology continues to enhance diagnostic accuracy, speed, and patient care quality, making early detection and personalized treatment possible. Here’s a summary of key advancements in radiology by some of the leading companies: Koninklijke Philips: Philips is enhancing minimally invasive procedures with its Azurion platform, which combines AI for real-time imaging improvements, supporting safer and more precise treatments. The platform’s integration of advanced imaging systems helps shorten procedure times and improves patient outcomes. GE HealthCare: Known for innovations in cardiovascular radiology, GE Healthcare’s Allia IGS 7 system integrates robotics with advanced imaging, giving surgeons real-time visual guidance. This technology significantly enhances precision in complex procedures, particularly for heart and vascular conditions. Siemens Healthineers: Siemens' Artis Icono platform is designed for a range of interventional applications, offering adaptive imaging capabilities tailored to each patient. This system is valuable for neurology and oncology, where patient-specific visualization enhances procedural accuracy. Canon Medical Systems Corporation: Canon’s Alphenix platform provides high-quality 3D imaging that’s versatile for various interventional applications, from vascular to oncology. The platform's precision and versatility in imaging are instrumental in complex, minimally invasive procedures. Fujifilm Healthcare UK: Fujifilm emphasizes efficiency and patient safety with its Synapse PACS, which leverages AI for streamlined diagnostics and workflow. This technology enhances decision-making speed and quality in radiology departments, crucial for interventional radiology’s rapid advancements. Toshiba Medical Systems Asia (part of Canon): Toshiba’s Aquilion ONE CT series captures high-quality images in one rotation, which is critical for timely interventional procedures, especially in cardiac and neurological imaging. The reduced radiation exposure and high speed of this technology are significant benefits for patients. #WorldRadiologyDay, #HappyRadiologyDay, #RadiologyDay2024, #RadiologyAwareness, #ImagingInnovation, #RadiologyHeroes, #XrayAnniversary, #MedicalImaging, #PowerOfRadiology, #RadiologyAndAI, #GreenRadiology, #FutureOfRadiology, #PatientCareInFocus We’ve prepared a service to support you. Please feel free to contact us at? [email protected]

CPHI Barcelona is set to bring together over 40,000 executives from across the pharmaceutical supply chain at Fira Barcelona from October 24 to 26. This highly anticipated event is not only a premier business showcase but also an invaluable platform for meaningful discussions on outsourcing and the latest advancements in the pharmaceutical and biotech sectors. The global pharmaceutical CDMO market size was estimated at US$ 146.05 billion in 2023 and is projected to grow to US$ 315.08 billion by 2034, rising at a CAGR of 7.24% from 2024 to 2034.? Source: https://lnkd.in/dpVHUvw6 ???????????????????????????? ???????? ???????????? ???????????? ?? In October 2024,?Strides Pharma Inc.?reported that during the pre-listing phase, both domestic and overseas institutional investors committed Rs 801 crore in equity to its affiliate company. ??In June 2023,?Lifera, a commercial-scale contract development and manufacturing organization (CDMO), was introduced by the Public Investment Fund (PIF), Saudi Arabia's international investment institution. ??The CDMO will promote Saudi Arabia's status as a major worldwide location for pharmaceutical manufacture, boost national resilience, and facilitate the expansion of the regional bio/pharmaceutical sector. ??In March 2023, with funding from a UK Government grant, Pharmaron spent ￡151 million in UK Gene Therapy CDMO to increase the size of its facilities for producing viral vectors and DNA by over 8,000 square meters. Stay connected with us through our annual membership: https://lnkd.in/ds9rtPbb ???????????? ???????????????????????? ???? ?????? ???????????????????????????? ???????? ???????????? ?? In October 2023,?the CDMO Intelligence solution from Norstella firm Evaluate was launched today. In order to make well-informed judgments and maximize long-term strategies in the intricate and quickly growing pharmaceutical CDMO industry, it will give contract development and manufacturing organizations (CDMOs), biopharma businesses, and finance institutions thorough and objective market knowledge. ?? In September 2023, the CDMO service was just launched by Future Fields, a biotechnology business that developed the first synthetic biology system in the world to employ fruit flies for the creation of recombinant proteins. Buy premium insight now: https://lnkd.in/dBTQ65Af #CPHIBarcelona #PharmaceuticalIndustry #Biotech #CDMO #ContractDevelopmentManufacturing #PharmaOutsourcing #PharmaceuticalMarket #Biopharma #PharmaceuticalInnovation #HealthcareSolutions #GeneTherapy #SyntheticBiology #PharmaTrends #MarketResearch #HealthcareConsulting #PharmaGrowth #BioPharmaSector #PharmaceuticalManufacturing #SaudiPharma #GlobalPharma #DrugManufacturing #PharmaceuticalInsights

The global resorbable nerve conduits market, valued at US$ 2.31 billion in 2023, is projected to grow to US$ 5.28 billion by 2034, with a CAGR of 7.8%. This growth is driven by the rising demand for treatments that minimize inflammation and support nerve regeneration. Get the latest insights on industry segmentation with our Annual Membership: https://lnkd.in/ds9rtPbb Leading Companies in the Resorbable Nerve Conduits Market axogen: Known for its Avance? Nerve Graft and resorbable nerve conduits that enhance nerve regeneration. Integra LifeSciences: Offers a range of nerve repair solutions, improving patient recovery through resorbable nerve conduits. Boston Scientific: Integrating resorbable materials into nerve repair products to support regeneration. Medtronic: Provides advanced tools for nerve injury repair, including resorbable conduits that aid in recovery. Baxter International Inc.: Offers resorbable nerve conduits as part of their neurosurgery solutions, helping restore nerve function. Regenity Biosciences: Specializes in biologic products for nerve regeneration, with an emphasis on resorbable nerve conduits. Buy Premium Global Insight: https://lnkd.in/dK2JrizK #NerveRepair #MedicalInnovation #ResorbableNerveConduits #Healthcare #PatientCare

The disposable diabetes lancets market was valued at approximately $1.19 billion in 2023 and is expected to reach $1.9 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.33% from 2024 to 2034. Get the latest insights on industry segmentation with our Annual Membership: https://lnkd.in/ds9rtPbb Key Companies Leading the Disposable Diabetes Lancets Market Several companies are at the forefront of driving innovation in the disposable diabetes lancets market. Here’s a closer look at some of the key players: A.Menarini Diagnostics A leader in diagnostics, Menarini has built a strong reputation in the medical device industry, providing cutting-edge diabetes care solutions. Acon Diabetes Care: Known for its high-quality blood glucose meters and lancets, Acon Diabetes Care is committed to making diabetes management easier for patients worldwide. AdvaCare Pharma USA: AdvaCare Pharma is a well-established global supplier of medical devices, offering a wide range of diabetic testing tools including lancets designed for safety and ease of use. ARKRAY Healthcare Pvt. Ltd.: With a focus on innovation, Arkray Healthcare provides reliable diagnostic products, including advanced lancets and testing equipment designed for both home and clinical settings. BioCare Corporation: BioCare is recognized for its commitment to delivering medical solutions that prioritize user comfort and safety, helping patients manage their health with ease. CVS Pharmacy: As one of the largest pharmacy chains in the U.S., CVS Pharmacy plays a vital role in providing patients with access to high-quality diabetic testing supplies, including disposable lancets. Drawbridge Health: This innovative company is known for its breakthrough solutions in at-home health monitoring, including the recently FDA-approved NanoDrop Lancet. Genteel: Genteel is renowned for its precision lancets and lancing devices that reduce pain and make blood sampling more comfortable for users. Hoffman La-Roche Ltd.: A global leader in the healthcare industry, Roche provides comprehensive diabetes care solutions, from lancets to advanced glucose monitoring devices. Owen Mumford: Owen Mumford is an expert in medical devices, offering precision-engineered lancets that meet the highest standards of safety and reliability. Pip Diabetes Care: Pip Diabetes is gaining attention for its innovative, pain-free lancets that are designed with patient comfort in mind, helping to improve the diabetes testing experience. SD BIOSENSOR HEALTHCARE PRIVATE LIMITED: SD Biosensor is a prominent player in the diabetes care industry, offering a wide range of diagnostic tools, including lancets, that meet the needs of patients worldwide. Buy Premium Global Insight: https://lnkd.in/div4mya4 #DiabetesCare #HealthTech #Innovation #DiabetesManagement #DisposableLancets #MedicalDevices #HealthMonitoring #FutureOfHealthcare #DiabetesAwareness

The compounded topical drug market is set to experience significant growth over the next decade. Valued at US$ 4.27 billion in 2023, it is projected to reach US$ 6.78 billion by 2034, with a compound annual growth rate (CAGR) of 4.29%. This growth is largely fueled by the increasing demand for personalized medications and a rise in the incidence of skin disorders worldwide. Get the latest insights on industry segmentation with our Annual Membership: https://lnkd.in/ds9rtPbb Hello Cake: A sexual health startup that recently introduced innovative prescription medications like Libido Lift Rx and O-Cream, compounded by Epiq Scripts. EPIQ SCRIPTS: A digital pharmacy company that specializes in compounding personalized medications, enabling brands like Hello Cake to bring new solutions to market. Medisca: Known for its cutting-edge compounding technology, Medisca launched the MAZ Mixer, an advanced solution for uniform and high-quality medication compounding. Albertsons Companies: A well-established name offering compounded medications as part of its comprehensive healthcare services. Apollo Clinical Pharmacy: A pharmacy that focuses on customized solutions tailored to individual patient needs. Aurora Health Care: A trusted healthcare provider offering compounded medications to support patient care. BKK B. Braun Melsungen AG : A global leader in pharmaceutical and medical technology, providing quality compounded medications for hospitals and clinics. Calgary Co-op: A community-focused pharmacy offering personalized compounding solutions to local patients. Nephron Pharmaceuticals: Specializes in custom compounding for patients with complex health needs. PCCA: A leader in providing resources and training to compounding pharmacies, ensuring the highest standards of medication preparation. ReNue Rx : Known for delivering specialized compounded medications tailored to patients’ needs. SaveWay Compounding Pharmacy: Focused on providing individualized care with personalized compounded medications. Triangle Compounding Pharmacy : Offers a variety of customized medications, ensuring patient-centered care. Buy Premium Global Insight: https://lnkd.in/dv4GXryh #CompoundingPharmacy #HealthcareInnovation #PersonalizedMedicine #Pharmaceuticals #PatientCare

LSPedia partnered with Pharma Logistics to enhance compliance, data visibility, and supply chain efficiency. India's government initiatives, such as PM Gati Shakti and the National Logistics Policy, along with digital advancements like the Unified Logistics Interface Program (ULIP), are boosting the sector's momentum. Cardinal Health reported a strong Q4 revenue growth of 12%, reaching $59.9 billion, with FY 2024 revenue up by 11% at $226.8 billion. Pharmaceuticals ranked as the world's 7th most traded product in 2022, with a total trade of $835 billion. Germany, Switzerland, the U.S., Ireland, and Belgium led exports, while the U.S., Germany, Switzerland, Belgium, and China led imports. The pharmaceutical logistics market was estimated at US$ 105.6 billion in 2023 and is projected to grow to US$ 191.1?billion by 2034, rising at a compound annual growth rate (CAGR) of 5.54%?from 2024 to 2034. Get the latest insights on industry segmentation with our Annual Membership: https://lnkd.in/ds9rtPbb Recent developments include NIPPON EXPRESS GROUP GmBH’s GDP certification for pharmaceutical storage and forwarding in Budapest, and MD Logistics’ upgrade of its Plainfield warehouse to a cGMP-compliant facility, ensuring high standards for pharmaceutical logistics. The pharmaceutical logistics market is driven by key players known for their innovation and excellence in delivering safe, efficient, and compliant logistics solutions. Agility Logistics leverages cutting-edge technology and a global network to streamline supply chains and enhance transparency for pharmaceutical shipments worldwide. AmerisourceBergen Global Services focuses on innovative solutions to optimize pharmaceutical distribution, with a strong emphasis on data analytics, ensuring timely delivery and product integrity. Cardinal Health, Inc. is a leader in pharmaceutical and medical product distribution, known for its digital platforms that improve traceability, compliance, and customer satisfaction. Its significant revenue growth highlights its pivotal role in the sector. CEVA Logistics excels in end-to-end supply chain solutions, with specialized temperature-controlled services for sensitive pharmaceutical products, ensuring product integrity throughout transit. C.H. Robinson integrates digital tools to simplify complex logistics needs, offering real-time visibility and efficient supply chain solutions that are vital for pharmaceutical logistics. Buy premium report now: https://lnkd.in/gQN_ef2W #PharmaLogistics #SupplyChainInnovation #PharmaceuticalIndustry #HealthcareLogistics #ColdChainLogistics #LifeSciences #SupplyChainVisibility #PharmaSupplyChain #LogisticsTechnology